Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
Clinical Trials Today: Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer...


(3 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Conducting Clinical Trials in Rare Oncology

Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...


(3 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Rare Disease Research in Central and Eastern Europe

There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world....


(3 minute read)

Tags: Rare & Orphan Disease

Understanding the Importance of Location in Rare Disease Studies

Rare disease isn’t rare. As a whole, more than 350 million people in the world have at least one rare disease – more than the...


(4 minute read)

Tags: Rare & Orphan Disease, Global Coverage

Impact of COVID-19 on Rare Disease Research

COVID-19 moved from a ubiquitous virus to a full-on pandemic very quickly. As countries and city centers took steps to stem...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights, COVID-19

The Importance of Natural History Study to Rare Disease Drug Development

Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Managing Patient Enrollment in Acromegaly Rare Disease Studies

In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover